Profile
Myra Rosario Herrle worked as a Senior Director in Oncology Global Regulatory Affairs at AbbVie, Inc. from 2014 to 2020.
Prior to that, she was a Director in Oncology Biomarkers at GSK Plc from 2001 to 2005 and an Associate Director in Oncology Regulatory Affairs at Novartis Pharmaceuticals Corp.
from 2005 to 2014.
She also worked as a Vice President in Regulatory Affairs at GlycoMimetics, Inc. Additionally, she is currently working as an Executive Vice President in Regulatory Affairs at POINT Biopharma Global, Inc. from 2021 to 2023.
Dr. Herrle received her undergraduate degree from the University of Puerto Rico School of Medicine.
Former positions of Myra Rosario Herrle
| Companies | Position | End |
|---|---|---|
| POIT BIOP | General Counsel | 2023-12-26 |
| ABBVIE INC. | Corporate Officer/Principal | 2020-02-29 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2014-07-31 |
| GSK PLC | Corporate Officer/Principal | 2004-12-31 |
| GLYCOMIMETICS, INC. | General Counsel | - |
Training of Myra Rosario Herrle
| University of Puerto Rico School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| GSK PLC | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| POIT BIOP | Health Technology |
| Private companies | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Myra Rosario Herrle